Cannabis cue-elicited craving and the reward neurocircuitry

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 38, Issue 1, 2012, Pages 30-35

  Filbey, Francesca M ^a   DeWitt, Samuel J ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Cue reactivity; FMRI; Marijuana; Nucleus accumbens; Ventral tegmental area

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS; DOPAMINE; ENDOCANNABINOID; FATTY ACID AMIDASE;

ARTICLE; ASSOCIATION; CANNABIS ADDICTION; CONDITIONING; DOPAMINERGIC SYSTEM; DRUG SEEKING BEHAVIOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NERVE STIMULATION; NEUROBIOLOGY; NONHUMAN; ORBITAL CORTEX; RECEPTOR BINDING; REINFORCEMENT; REWARD; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; CANNABINOIDS; CANNABIS; MOTIVATION; NEURAL PATHWAYS; REWARD;

EID: 84862853573     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.11.001     Document Type: Article

References (45)

1. Bordnick P.S., Copp H.L., Traylor A., Graap K.M., Carter B.L., Walton A., et al. Reactivity to cannabis cues in virtual reality environments. J Psychoactive Drugs 2009, 41:105-112.
2. Bossong M.G., van Berckel B.N., Boellaard R., Zuurman L., Schuit R.C., Windhorst A.D., et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2009, 34:759-766.
3. Cheer J.F., Kendall D.A., Marsden C.A. Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology 2000, 151:25-30.
4. Chen J.P., Paredes W., Li J., Smith D., Lowinson J., Gardner E.L. Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 1990, 102:156-162.
5. Cooper Z.D., Haney M. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol 2008, 13:188-195.
6. Fadda P., Scherma M., Spano M.S., Salis P., Melis V., Fattore L., et al. Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport 2006, 17:1629-1632.
7. Fattore L., Fadda P., Spano M.S., Pistis M., Fratta W. Neurobiological mechanisms of cannabinoid addiction. Mol Cell Endocrinol 2008, 286:S97-S107.
8. Fattore L., Spano M.S., Altea S., Fadda P., Fratta W. Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br J Pharmacol 2010, 160:724-735.
9. Field M., Eastwood B., Bradley B.P., Mogg K. Selective processing of cannabis cues in regular cannabis users. Drug Alcohol Depend 2006, 85:75-82.
10. Filbey F.M., Claus E.D., Hutchison K.E. A neuroimaging approach to the study of craving. Neuroimaging in addiction 2011, 133-156. Wiley-Blackwell, London. A. Adinoff, E. Stein (Eds.).
11. Filbey F.M., Schacht J.P., Myers U.S., Chavez R.S., Hutchison K.E. Marijuana craving in the brain. Proc Natl Acad Sci U S A 2009, 106:13016-13021.
12. Filbey F.M., Schacht J.P., Myers U.S., Chavez R.S., Hutchison K.E. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology 2010, 35:967-975.
13. French E.D., Dillon K., Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 1997, 8:649-652.
14. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 2005, 81:263-284.
15. Gessa G.L., Melis M., Muntoni A.L., Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 1998, 341:39-44.
16. Gray K.M., LaRowe S.D., Upadhyaya H.P. Cue reactivity in young marijuana smokers: a preliminary investigation. Psychol Addict Behav 2008, 22:582-586.
17. Haughey H.M., Marshall E., Schacht J.P., Louis A., Hutchison K.E. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction 2008, 103:1678-1686.
18. Hoffman A.F., Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 2001, 85:72-83.
19. Hommer D.W. Functional imaging of craving. Alcohol Res Health 1999, 23:187-196.
20. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
21. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 1992, 450:455-468.
22. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:1403-1413.
23. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
24. Lundahl L.H., Johanson C.E. Cue-induced craving for marijuana in cannabis-dependent adults. Exp Clin Psychopharmacol 2011, 19:224-230.
25. Lupica C.R., Riegel A.C., Hoffman A.F. Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 2004, 143:227-234.
26. Malone D.T., Taylor D.A. Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats. Br J Pharmacol 1999, 128:21-26.
27. Marinelli S., Di Marzo V., Florenzano F., Fezza F., Viscomi M.T., van der Stelt M., et al. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology 2007, 32:298-308.
28. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
29. McRae-Clark A.L., Carter R.E., Price K.L., Baker N.L., Thomas S., Saladin M.E., et al. Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals. Psychopharmacology 2011, 218(1):49-58.
30. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 2004, 24:53-62.
31. Ng Cheong Ton J.M., Gerhardt G.A., Friedemann M., Etgen A.M., Rose G.M., Sharpless N.S., et al. The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res 1988, 451:59-68.
32. Nickerson Lisa D., Ravichandran Caitlin, Lundahl Leslie H., Rodolico John, Dunlap Steven, Trksak George H., Lukas Scott E. Cue reactivity in cannabis-dependent adolescents. Psychol Addict Behav 2011, 25(1):168-173.
33. Robbe D., Kopf M., Remaury A., Bockaert J., Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci U S A 2002, 99:8384-8388.
34. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
35. Robinson T.E., Berridge K.C. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 2008, 363:3137-3146.
36. Schacht J.P., Selling R.E., Hutchison K.E. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology 2009, 203:511-517.
37. Singleton E.G., Trotman A.J., Zavahir M., Taylor R.C., Heishman S.J. Determination of the reliability and validity of the Marijuana Craving Questionnaire using imagery scripts. Exp Clin Psychopharmacol 2002, 10:47-53.
38. Solinas M., Justinova Z., Goldberg S.R., Tanda G. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J Neurochem 2006, 98:408-419.
39. Solinas M., Yasar S., Goldberg S.R. Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol Res 2007, 56:393-405.
40. Tanda G., Munzar P., Goldberg S.R. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 2000, 3:1073-1074.
41. Volkow N.D., Fowler J.S., Wang G.J., Goldstein R.Z. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 2002, 78:610-624.
42. Wenger T., Moldrich G., Furst S. Neuromorphological background of cannabis addiction. Brain Res Bull 2003, 61:125-128.
43. Wise R.A. The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 1988, 97:118-132.
44. Wolfling K., Flor H., Grusser S.M. Psychophysiological responses to drug-associated stimuli in chronic heavy cannabis use. Eur J Neurosci 2008, 27:976-983.
45. Yamamoto T., Takada K. Role of cannabinoid receptor in the brain as it relates to drug reward. Jpn J Pharmacol 2000, 84:229-236.